Pyrazine derivatives as modulators of tyrosine kinases

Details for Australian Patent Application No. 2001294584 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Connolly, Peter; Wang, Aihua; Middleton, Steve; Emanuel, Stuart; Deangelis, Alan; Prouty, Catherine; Jolliffe, Linda; Kuo, Gee Hong

Agent Shelston IP

Pub. Number AU-B-2001294584

PCT Pub. Number WO02/24681

Priority 60233968 20.09.00 US

Filing date 19 September 2001

Wipo publication date 2 April 2002

Acceptance publication date 23 March 2006

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

23 March 2006 Application Accepted

  Published as AU-B-2001294584

20 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001294585

2001294583